As the holiday season approaches and social gatherings become more frequent, new research serves as a timely reminder to consider the long-term health implications of alcohol consumption. Although alcohol is widely known to increase the risk of several cancers, even at levels many regard as moderate, drinking remains common across the United States. This disconnect has left important questions unresolved about how both the frequency and quantity of alcohol intake shape cancer risk, and why public awareness and policy often fail to highlight cancer as a key consequence of drinking.
Health risks linked to alcohol are not evenly shared across the population. Biological differences, social conditions, and patterns of exposure mean that some groups experience far greater harm than others. Despite this, alcohol policies and public health messaging have tended to focus on immediate harms such as liver disease or injury, rather than cancer prevention. To address these gaps, researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine conducted a comprehensive systematic review examining how different levels of alcohol consumption affect cancer risk among U.S. adults.
The review analysed data from 62 studies, with participant numbers ranging from just 80 individuals to nearly 100 million. This broad evidence base allowed the researchers to assess cancer risk across diverse populations and drinking patterns, including excessive, moderate, and mild alcohol use. The analysis also accounted for comorbid conditions such as obesity and chronic liver disease, which are known to increase vulnerability. It examined how social and demographic factors influence exposure and outcomes.
Published in the journal Cancer Epidemiology, the findings confirmed that both how often people drink and how much they consume significantly affect cancer risk. Strong associations were identified for breast, colorectal, liver, oral, laryngeal, oesophageal, and gastric cancers. Alcohol was also linked to poorer outcomes once cancer develops; for example, individuals with alcoholic liver disease were more likely to present with advanced liver cancer and experienced lower survival rates. Higher alcohol intake was associated with particularly elevated risk among African Americans, people with genetic predispositions, and individuals with obesity or diabetes. Factors such as race, age, income, and education further shaped vulnerability, leaving lower socioeconomic and some racial or ethnic groups disproportionately affected despite similar or lower levels of consumption.
The review also highlighted that healthier lifestyle choices can reduce risk. Following guidance from organisations such as the American Cancer Society—combining limited alcohol intake with broader healthy behaviours—was associated with lower cancer incidence and mortality. The researchers noted additional complexities, including differences by beverage type and sex, with some evidence that frequent drinking posed a greater risk for men. In contrast, episodic heavy drinking was more harmful for women. Smoking amplified alcohol-related cancer risk, and factors such as infections, low physical activity, and poor diet further compounded harm. Overall, the authors emphasise that alcohol-related cancer risk arises from a complex interaction of biological, behavioural, and social factors, underscoring the need for clearer public messaging, stronger policies, and targeted interventions to reduce preventable cancer burden.
More information: Isabella Abraham et al, A systematic review on the risk of developing cancer and frequency of alcohol consumption behaviors in US adults, Cancer Epidemiology. DOI: 10.1016/j.canep.2025.102956
Journal information: Cancer Epidemiology Provided by Florida Atlantic University
